Channel Expansion Fenwal operates within the Fresenius Kabi portfolio, offering transfusion medicine technologies. This provides a direct pathway to hospitals, blood banks, and clinicians through established Fresenius Kabi channels for cross-sell opportunities.

Safety and Efficiency As a global blood technology leader focused on collection, storage, and transfusion, there is demand for safer, more efficient workflows, including automation, traceability, and compliance solutions that reduce risk.

Cell Therapy Support Fenwal’s blood technology and transfusion capabilities align with cell and gene therapy workflows, presenting upsell opportunities to biotech and hospital systems seeking integrated collection, processing, and storage solutions.

Global Growth Leveraging its global footprint and Fresenius Kabi backing, Fenwal can expand into new regions and health systems, leveraging existing relationships with blood centers and medical device distributors.

Enterprise Partnerships Target mid-to-large hospitals, blood banks, and health systems with scalable equipment, service contracts, and training programs that deepen device adoption and generate recurring revenue.